|
|
Volumn 2, Issue 2, 1997, Pages 47-49
|
|
Growing threat of Gram-positive resistance a challenge to the industry
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOGLYCOSIDE;
ANTIINFECTIVE AGENT;
BAY 12803;
CIPROFLOXACIN;
CL 331002;
DALFOPRISTIN;
DALFOPRISTIN PLUS QUINUPRISTIN;
EPEREZOLID;
ERYTHROMYCIN;
EVERNINOMICIN;
GLYCOPEPTIDE;
HMR 3004;
LINEZOLID;
MACROLIDE;
ORITAVANCIN;
PENICILLIN DERIVATIVE;
PENICILLIN G;
SPARFLOXACIN;
STREPTOGRAMIN;
TELITHROMYCIN;
TETRACYCLINE DERIVATIVE;
TROVAFLOXACIN;
UNCLASSIFIED DRUG;
VANCOMYCIN;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC RESISTANCE;
BACTERIAL INFECTION;
DRUG DEVELOPMENT;
GRAM POSITIVE BACTERIUM;
NONHUMAN;
SHORT SURVEY;
|
|
EID: 0030814167
PISSN: 13596446
EISSN: None
Source Type: Journal
DOI: 10.1016/S1359-6446(97)83291-6 Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|